Diabetes Devices Market Size, Share, and Trends 2024 to 2034

The global diabetes devices market size was USD 30.40 billion in 2023, calculated at USD 32.74 billion in 2024 and is projected to surpass around USD 68.75 billion by 2034, expanding at a CAGR of 7.7% from 2024 to 2034.

  • Last Updated : November 2023
  • Report Code : 1321
  • Category : Healthcare

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

5.1. Market Dynamics

5.1.1. Market Drivers

5.1.2. Market Restraints

5.1.3. Market Opportunities

5.2. Porter’s Five Forces Analysis

5.2.1. Bargaining power of suppliers

5.2.2. Bargaining power of buyers

5.2.3. Threat of substitute

5.2.4. Threat of new entrants

5.2.5. Degree of competition

Chapter 6. Competitive Landscape

6.1.1. Company Market Share/Positioning Analysis

6.1.2. Key Strategies Adopted by Players

6.1.3. Vendor Landscape

6.1.3.1. List of Suppliers

6.1.3.2. List of Buyers

Chapter 7. Global Diabetes Devices Market, By Type

7.1. Diabetes Devices Market, by Type, 2024-2034

7.1.1. Blood Glucose Monitoring

7.1.1.1. Market Revenue and Forecast (2021-2034)

7.1.2. Insulin Delivery Devices

7.1.2.1. Market Revenue and Forecast (2021-2034) 

Chapter 8. Global Diabetes Devices Market, By Application

8.1. Diabetes Devices Market, by Application, 2024-2034

8.1.1. Diagnostic Center

8.1.1.1. Market Revenue and Forecast (2021-2034)

8.1.2. Hospitals

8.1.2.1. Market Revenue and Forecast (2021-2034)

8.1.3. Home Care

8.1.3.1. Market Revenue and Forecast (2021-2034)

Chapter 9. Global Diabetes Devices Market, By Distribution Channel 

9.1. Diabetes Devices Market, by Distribution Channel, 2024-2034

9.1.1. Retail Pharmacy

9.1.1.1. Market Revenue and Forecast (2021-2034)

9.1.2. Hospital Pharmacy

9.1.2.1. Market Revenue and Forecast (2021-2034)

9.1.3. Clinics

9.1.3.1. Market Revenue and Forecast (2021-2034)

9.1.4. Online Pharmacy

9.1.4.1. Market Revenue and Forecast (2021-2034)

9.1.5. Others

9.1.5.1. Market Revenue and Forecast (2021-2034)

Chapter 10. Global Diabetes Devices Market, Regional Estimates and Trend Forecast

10.1. North America

10.1.1. Market Revenue and Forecast, by Type (2021-2034)

10.1.2. Market Revenue and Forecast, by Application (2021-2034)

10.1.3. Market Revenue and Forecast, by Distribution Channel (2021-2034)

10.1.4. U.S.

10.1.4.1. Market Revenue and Forecast, by Type (2021-2034)

10.1.4.2. Market Revenue and Forecast, by Application (2021-2034)

10.1.4.3. Market Revenue and Forecast, by Distribution Channel (2021-2034)

10.1.5. Rest of North America

10.1.5.1. Market Revenue and Forecast, by Type (2021-2034)

10.1.5.2. Market Revenue and Forecast, by Application (2021-2034)

10.1.5.3. Market Revenue and Forecast, by Distribution Channel (2021-2034)

10.2. Europe

10.2.1. Market Revenue and Forecast, by Type (2021-2034)

10.2.2. Market Revenue and Forecast, by Application (2021-2034)

10.2.3. Market Revenue and Forecast, by Distribution Channel (2021-2034)

10.2.4. UK

10.2.4.1. Market Revenue and Forecast, by Type (2021-2034)

10.2.4.2. Market Revenue and Forecast, by Application (2021-2034)

10.2.4.3. Market Revenue and Forecast, by Distribution Channel (2021-2034)

10.2.5. Germany

10.2.5.1. Market Revenue and Forecast, by Type (2021-2034)

10.2.5.2. Market Revenue and Forecast, by Application (2021-2034)

10.2.5.3. Market Revenue and Forecast, by Distribution Channel (2021-2034)

10.2.6. France

10.2.6.1. Market Revenue and Forecast, by Type (2021-2034)

10.2.6.2. Market Revenue and Forecast, by Application (2021-2034)

10.2.6.3. Market Revenue and Forecast, by Distribution Channel (2021-2034)

10.2.7. Rest of Europe

10.2.7.1. Market Revenue and Forecast, by Type (2021-2034)

10.2.7.2. Market Revenue and Forecast, by Application (2021-2034)

10.2.7.3. Market Revenue and Forecast, by Distribution Channel (2021-2034)

10.3. APAC

10.3.1. Market Revenue and Forecast, by Type (2021-2034)

10.3.2. Market Revenue and Forecast, by Application (2021-2034)

10.3.3. Market Revenue and Forecast, by Distribution Channel (2021-2034)

10.3.4. India

10.3.4.1. Market Revenue and Forecast, by Type (2021-2034)

10.3.4.2. Market Revenue and Forecast, by Application (2021-2034)

10.3.4.3. Market Revenue and Forecast, by Distribution Channel (2021-2034)

10.3.5. China

10.3.5.1. Market Revenue and Forecast, by Type (2021-2034)

10.3.5.2. Market Revenue and Forecast, by Application (2021-2034)

10.3.5.3. Market Revenue and Forecast, by Distribution Channel (2021-2034)

10.3.6. Japan

10.3.6.1. Market Revenue and Forecast, by Type (2021-2034)

10.3.6.2. Market Revenue and Forecast, by Application (2021-2034)

10.3.6.3. Market Revenue and Forecast, by Distribution Channel (2021-2034)

10.3.7. Rest of APAC

10.3.7.1. Market Revenue and Forecast, by Type (2021-2034)

10.3.7.2. Market Revenue and Forecast, by Application (2021-2034)

10.3.7.3. Market Revenue and Forecast, by Distribution Channel (2021-2034)

10.4. MEA

10.4.1. Market Revenue and Forecast, by Type (2021-2034)

10.4.2. Market Revenue and Forecast, by Application (2021-2034)

10.4.3. Market Revenue and Forecast, by Distribution Channel (2021-2034)

10.4.4. GCC

10.4.4.1. Market Revenue and Forecast, by Type (2021-2034)

10.4.4.2. Market Revenue and Forecast, by Application (2021-2034)

10.4.4.3. Market Revenue and Forecast, by Distribution Channel (2021-2034)

10.4.5. North Africa

10.4.5.1. Market Revenue and Forecast, by Type (2021-2034)

10.4.5.2. Market Revenue and Forecast, by Application (2021-2034)

10.4.5.3. Market Revenue and Forecast, by Distribution Channel (2021-2034)

10.4.6. South Africa

10.4.6.1. Market Revenue and Forecast, by Type (2021-2034)

10.4.6.2. Market Revenue and Forecast, by Application (2021-2034)

10.4.6.3. Market Revenue and Forecast, by Distribution Channel (2021-2034)

10.4.7. Rest of MEA

10.4.7.1. Market Revenue and Forecast, by Type (2021-2034)

10.4.7.2. Market Revenue and Forecast, by Application (2021-2034)

10.4.7.3. Market Revenue and Forecast, by Distribution Channel (2021-2034)

10.5. Latin America

10.5.1. Market Revenue and Forecast, by Type (2021-2034)

10.5.2. Market Revenue and Forecast, by Application (2021-2034)

10.5.3. Market Revenue and Forecast, by Distribution Channel (2021-2034)

10.5.4. Brazil

10.5.4.1. Market Revenue and Forecast, by Type (2021-2034)

10.5.4.2. Market Revenue and Forecast, by Application (2021-2034)

10.5.4.3. Market Revenue and Forecast, by Distribution Channel (2021-2034)

10.5.5. Rest of LATAM

10.5.5.1. Market Revenue and Forecast, by Type (2021-2034)

10.5.5.2. Market Revenue and Forecast, by Application (2021-2034)

10.5.5.3. Market Revenue and Forecast, by Distribution Channel (2021-2034)

Chapter 11. Company Profiles

11.1. B Braun Melsungen AG

11.1.1. Company Overview

11.1.2. Product Offerings

11.1.3. Financial Performance

11.1.4. Recent Initiatives

11.2. Abbott Laboratories

11.2.1. Company Overview

11.2.2. Product Offerings

11.2.3. Financial Performance

11.2.4. Recent Initiatives

11.3. Bayer AG

11.3.1. Company Overview

11.3.2. Product Offerings

11.3.3. Financial Performance

11.3.4. Recent Initiatives

11.4. Medtronic Plc

11.4.1. Company Overview

11.4.2. Product Offerings

11.4.3. Financial Performance

11.4.4. Recent Initiatives

11.5. F.Hoffman-La-Ltd.

11.5.1. Company Overview

11.5.2. Product Offerings

11.5.3. Financial Performance

11.5.4. Recent Initiatives

11.6. Lifescan, Inc.

11.6.1. Company Overview

11.6.2. Product Offerings

11.6.3. Financial Performance

11.6.4. Recent Initiatives

11.7. Dexcom, Inc.

11.7.1. Company Overview

11.7.2. Product Offerings

11.7.3. Financial Performance

11.7.4. Recent Initiatives

11.8. Sanofi

11.8.1. Company Overview

11.8.2. Product Offerings

11.8.3. Financial Performance

11.8.4. Recent Initiatives

11.9. Tandem Diabetes Care, Inc.

11.9.1. Company Overview

11.9.2. Product Offerings

11.9.3. Financial Performance

11.9.4. Recent Initiatives

11.10. Companion Medical

11.10.1. Company Overview

11.10.2. Product Offerings

11.10.3. Financial Performance

11.10.4. Recent Initiatives

Chapter 12. Research Methodology

12.1. Primary Research

12.2. Secondary Research

12.3. Assumptions

Chapter 13. Appendix

13.1. About Us

13.2. Glossary of Terms

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client